We report biochemical evidence that epidermal growth factor and platelet-derived growth factor stimulate the Ras gua nucleotide exchange factor activity in quiescent NIH 3T3 cells. Moreover, the exchange activity is costutively enhanced in NIH 3T3 cells transformed by Src and ErbB2 oncogenic tyrosine protein kinases (TPKs), whereas transformation by oncogenic Mos and Raf does not alter the activity. GTPase-activating protein activity was not affected under these conditions. Overexpression of pp6O"src mutants contining activated and suppressor TPK mutations resulted in stimulation and inhibition ofthe exchange factor activity, respectively. A TPK inhibitor, genistein, prevented the activation of the exchange factor in epidermal growth factor/platelet-derived growth factor-treated cells and src-transformed cels. Furthermore, the exchange factor activity bound to an antiphosphotyrosine antibody immunalnity column. These findings suggest that the ganine nucleotide exchange factor, but not GTPase-activating protein, plays a major role in the Ras activation in cell proliferation initiated by growth factor receptor TPKs and malignant transformation by oncogenic TPKs and that tyrosine phosphorylation of either the exchange factor or a tightly bound protein(s) may mediate the activation of the exchange factr by these TPKs.
phosphotyrosine antibody immunalnity column. These findings suggest that the ganine nucleotide exchange factor, but not GTPase-activating protein, plays a major role in the Ras activation in cell proliferation initiated by growth factor receptor TPKs and malignant transformation by oncogenic TPKs and that tyrosine phosphorylation of either the exchange factor or a tightly bound protein(s) may mediate the activation of the exchange factr by these TPKs.
It is generally accepted that Ras activity is controlled by two regulatory proteins (1) . The guanine nucleotide exchange factor catalyzes the exchange of bound GDP for external GTP and thus leads to an active GTP-bound form of Ras that transmits signals to the downstream Ras effector. In contrast, Ras-GTPase-activating protein (GAP) (2) and neurofibromatosis type 1 protein (3) generate an inactive GDP-bound form of Ras by promoting hydrolysis of GTP bound to Ras. Either the activation of the exchange factor or the suppression of GAP would be expected to result in the accumulation of Ras in an active GTP-bound state. Recently, the exchange activity of guanine nucleotides bound to Ras has been detected in various mammalian cell extracts (4) (5) (6) (7) . The gene encoding Ras-specific guanine nucleotide exchange (releasing) factor has been isolated from rat (8) , mouse (9, 10) , and human (11) tissues and shares extensive homology in the catalytic domain with yeast Saccharomyces cerevisiae CDC25 (12, 13) .
Mammalian cells also contain genes (mSOS-1 and -2; ref. 14) related to Drosophila SOS (15) , which is homologous to CDC25 and Saccharomyces pombe STE6 (16) . Despite their structural similarity, these mammalan gene products differ in molecular mass and in tissue distribution, suggesting the existence of a family of the exchange factors.
While some structural and functional aspects of the exchange factor have been revealed, it is not clear how the exchange factor is physiologically involved in the signal transduction pathway activated by growth signals. A number The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
of studies have shown an increase in the amount of active Ras-GTP complex in cells induced to proliferate with epidermal growth factor (EGF) (17, 18) and platelet-derived growth factor (PDGF) (19) , in cells transformed by oncogenes such as src, erbB2, abl, andfms (18, 20) , and in hemopoietic cells stimulated by T-cell receptor antibodies (21) , interleukin 2, 3, and 5, and granulocyte-macrophage colony-stimulating factor (22, 23) . These observations implicate the involvement of Ras-GTP formation in growth signaling mechanisms. We have recently found that nerve growth factor increased the amount of Ras-GTP and stimulated the activities of the exchange factor and GAP in PC12 cells leading to the neuronal differentiation of cells (24) . In this case, the activation of Ras might result from the dominance of the exchange factor activity over GAP activity. Some molecular genetic studies showed that PDGF, EGF, and insulin increased the rate ofguanine nucleotide binding to Ras and that this increase was associated with elevations in Ras-GTP levels (25, 26) .
Involvement of tyrosine kinases in the Ras activation has been suggested by the observations that EGF, PDGF, and nerve growth factor receptor tyrosine protein kinases (TPKs) and oncogenic TPKs increased the level of active Ras-GTP in the cells (18) (19) (20) . However, the mode of regulation of Ras activity by these TPKs is unknown. Recent studies do not seem to support the hypothesis that tyrosine phosphorylation of GAP regulates Ras by modulating GAP activity (20, 21) . Genetic analysis showed that Drosophila SOS acts downstream of the TPK receptor Sevenless (27) (24) .
Assay of GAP Activity. Cells were disrupted as described above. Ras proteins (0.4 ug) were incubated with 0.2 ,Ci of [(c-32PJGTP (3000 Ci/mmol) in 50 /4 of the reaction buffer at 37°C for 3 min, the binary complexes were incubated with the indicated amounts of cell extracts, and GDP and GTP eluted from immunoprecipitates were analyzed by thin layer chromatography (TLC) as described (24) .
Chrmatography. Cells were disrupted in 20 mM sodium phosphate, pH 7.5/1 mM EGTA/1 mM dithiothreitol/0.5% Nonidet P-40/aprotinin (10 pg/ml)/0.5 mM phenylmethylsulfonyl fluoride/l mM sodium orthovanadate/10 mM NaF as described (24) . Cell lysates were fractionated by a FPLC Mono Q HR5/5 column (Pharmacia) chromatography using a linear gradient of 0-0.3 M NaCl as described (24) .
For immunoaffinity fractionation with anti-phosphotyrosine antibody, 100 disrupted cells were solubilized in buffer A containing 0.2% sodium cholate. Lysates were centrifuged at 100,000 x g for 15 min, and the supernatants were mixed with 100 54 of anti-phosphotyrosine antibody 4G10-agarose prepared by the published method (29) for 60 min at 4°C. The resins were washed three times with washing buffer (10 mM Tris HCl, pH 7.6/5 mM EDTA/50 mM NaCl/50 mM NaF/ 100 pM sodium orthovanadate) containing 0.1% sodium cholate and were mixed with 10 mM phenyl phosphate in 200 ;4 of washing buffer for 30 min at 4°C. Twenty microliters of eluted samples was assayed for the exchange factor activity in 300 51 of reaction buffer.
RESULTS
Effects of EGF or PDGF on the Activities of the Exchange Factor and GAP. EGF and PDGF induce cellular DNA synthesis in NIH 3T3 cells, at least in part through Ras protein activity (30) , and one of the earliest responses ofcells to these growth factors is an increase in the amount ofactive Ras-GTP complex (17) (18) (19) . To investigate whether the exchange factor or GAP activity is altered in response to the growth factors, we first examined the effects of both EGF and PDGF on the activity of the exchange factor in NIH 3T3 cells. After the serum starvation of confluent cells, quiescent cells were treated with EGF (200 ng/ml) or PDGF (50 ng/ml) for 10 min, and cell lysates were prepared.
[3H]GDP-Ha-Ras complexes were incubated with the extracts in the presence of excess unlabeled GTP for 10 10 min after treatment of cells with EGF or PDGF and, thereafter, decreased (B.-Q.L., M.S., H.-f.K., and T.K., unpublished data). There was a correlation with the rapid and transient elevation in the exchange activity and the levels of Ras-GTP complexes, and the subsequent reduction in the Ras-GTP levels was associated with the further decrease in the exchange activity. To further analyze the effect of the growth factors on the exchange factor activity, cell extracts were partially purified by Mono Q anion-exchange chromatography and each fraction was assayed for [3H]GDP dissociation activity. The relative GDP release promoting activity (eluted at 0.12 M NaCl) increased 2-to 3-fold after stimulation by EGF or PDGF (Fig. 1) . To 3) or PDGF (50 ng/ml, bar 4) for 10 min at 37C, and the cells were disrupted in buffer A as described (17) . tyrosine residues are crucial for the biological activity of pp60'csrc (28, 33) . Overexpression of normal pp60c-src resulted in a moderate increase in [3H]GDP release promoting activity (12% above buffer control), but introduction of the Tyr-527 mutation in pp60c-src enhanced the activity by 4-fold compared to normal pp60c-src ( Table 1) . The mutation at Tyr-416 in pp60-src markedly suppressed the exchange activity. The level of exchange activity correlated with both TPK and transforming activities of pp60c-sm and the results provide evidence that TPK of pp60c-src induced the constitutive activation of the exchange factor activity. In contrast, GAP activity was not affected by the mutation at these tyrosine phosphorylation sites in pp60c-s5.
A TPK Inhibitor, Genistein, Suppresses the Exchange Factor Activation. In another set of experiments, we tested a tyrosine kinase inhibitor, genistein, for the inhibitory effect on the exchange factor activity. Genistein specifically inhibits TPK activities, such as EGF receptor, pp60c.sm, and ppllOgP-fes, but does not inhibit serine and threonine kinases, such as protein kinase C (34) . The enhancement of the exchange factor activity in EGF-or PDGF-treated cells was blocked when the cells were pretreated with the drug for 15 min, and the activity in activated Src-transformed cells was similarly inhibited by the drug (Table 2 ). More than 80% inhibition of the activity was achieved with genistein at 30 Ag/ml, which inhibited 90% of total TPK activities in both membrane and cytosolic fractions in vitro (M.S., B.-Q.L., H.-f.K., and T.K., unpublished data), whereas an inhibitor of protein kinase C, calphostin C (100 ng/ml) (35) , failed to inhibit the activation ofthe exchange activity (B.-Q.L., M.S., H.-f.K., and T.K., unpublished data). The addition of genistein (30 /ug/ml) to the reaction mixtures containing extracts from src-transformed cells or EGF/PDGF-treated cells had no significant effect on the exchange factor activity, implying that the suppression of the exchange factor activity in the drug-treated cells was not due to the direct inhibition of the exchange factor activity by genistein.
Affinty Purification of the Exchange Factor Activity by Immobilized Anti-Phosphotyrosine Antibody. Because our data showed that tyrosine kinase activity was required for EGF/ PDGF-induced and Src-induced activation of the exchange factor, we speculated that the exchange factor or its associ- cells were serum-starved in DMEM containing 0.2% calf serum for 24 hr and cell lysates were prepared as in Fig. 3 . For the exchange factor activity assay, [3H]GDP-Ras complexes (0.4 ,ug) were incubated with extracts (25 pg) or the homogenization buffer in the presence of 0.4 mM GTP, and the bound nucleotides were measured by immunoprecipitation. Activity [mean -SD (n = 3)] is shown as described in Fig. 1. [3H]GDP (33,000 cpm) was bound to Ras. For the GAP activity assay, [a-32P]GTP-Ras (0.4 p,g) was incubated with extracts (30 pg) and analyzed as described in Fig. 2 . For Src kinase assay, cell extracts (500 pg) were immunoprecipitated with 4 ug of rabbit anti-Src antibody. Immunoprecipitates were subjected to the in vitro kinase reaction using [y32P]ATP, and the amounts of 32p incorporated into pp60csrc were analyzed by SDS/PAGE, as described (26) . GAP activity is (GTP x 100)/(GTP + GDP). Specific activity: ±, very weak; +, moderate; +++, very strong. ating protein(s) might be tyrosine-phosphorylated. To test this hypothesis, we fractionated activated src-transformed cell extracts by affinity chromatography using immobilized antiphosphotyrosine antibody. More than 80%6 of the exchange factor activity was immunodepleted by the immunoaffinity resins. The fractions that eluted with 10 mM phenyl phosphate enhanced the exchange activity of Ras and did not have any effect on other types of small molecular mass G proteins, RaplA and RabiB, suggesting that the exchange factor bound was Ras-specific (Fig. 4) . Immunoblot analysis with antiphosphotyrosine antibody after gel electrophoresis showed that the eluted fraction contained phosphotyrosine-containing proteins with molecular masses between 30 and 180 kDa (B.-Q.L., M.S., H.-f.K., and T.K., unpublished data). Similar results were obtained with EGF-or PDGF-treated cells. The results indicate that the exchange factor could be either tyrosine-phosphorylated or associated with a phosphotyrosine-containing protein(s). The antibody against a 1.4-kb carboxyl-terminal region of CDC25mm containing its catalytic domain (provided by Dan Broek, University of Southern California) was used to detect the protein of the exchange factor family in the eluates. No protein in either whole-cell extracts or eluted fractions specifically reacted with the antibody on an immunoblot, raising the possibility that CDC25IM is not expressed in NIH 3T3 cells (B.-Q.L., M.S., H.-f.K., and T.K., unpublished data).
DISCUSSION Present biochemical studies demonstrate that the Ras guanine nucleotide exchange factor activity, but not GAP activ- Fig. 3 .
Activity [mean ± SD (n = 3)] is shown as described in Fig. 1 .
[3H]GDP (32,000 cpm) was bound to Ras without addition. The GDP release by buffer alone (2.0%o) was subtracted.
ity, was enhanced in EGF-or PDGF-stimulated cells and in oncogenic TPK-transformed cells. Since the increase in the amount of Ras-GTP complex correlated with the enhancement of the exchange factor activity, the activated factor might stimulate Ras activities by promoting the conversion of Ras-GDP to Ras-GTP in these biological systems, Ras-GAP or neurofibromatosis type 1 protein might simply play a role as a negative regulator and/or effector for Ras. This is consistent with the observation based on molecular genetic studies that stimulation of nucleotide exchange on Ras would be the predominant mechanism in PDGF-, EGF-, and insulintreated cells (25, 26) . In our previous study (24) , nerve growth factor was found to stimulate both the exchange factor and GAP activities in PC12 cells during the early stage of cell differentiation. In activated T lymphocytes, the activation of Ras appeared to involve a protein kinase C-induced decrease in GAP activity without alteration of the exchange factor activity (21) . The present results seem to differ from those described in the two systems above. Therefore, the mode of action of these Ras regulatory proteins could be different depending on the biological systems used.
Another major finding is that activation of the exchange factor is triggered by phosphorylation events induced by ligand stimulation of receptor TPKs and oncogenic TPKs. Fig. 3 . The activity is given as in Fig. 1 and data This can be drawn by the following facts. (i) Constitutive activation of the exchange factor was detected in Src or ErbB2 oncogenic TPK-transformed cells, whereas the response of the factor to EGF or PDGF was transient. (ii) Exchange factor activity was stimulated in the cells carrying a TPK-activated Src mutant and was suppressed in the cells carrying its TPK-defective mutant. (iii) Enhancement of the activity by EGF, PDGF, and activated Src was inhibited by treatment of cells with genistein, a TPK inhibitor, at a dose that inhibits TPK activity. The mechanism by which TPKs activate the exchange factor remains to be determined. Since the exchange factor activity was retained on an antiphosphotyrosine antibody-coupled resin, the simplest model would be the direct tyrosine phosphorylation of the factor by EGF/PDGF receptor TPKs and oncogenic Src/ErbB2 TPKs or by an as yet unidentified TPK activated by the above mentioned TPKs. Alternatively, tyrosine phosphorylation of a protein associating with the exchange factor could modulate the exchange factor activity. Recently, two Src homology 2 (SH2)-containing proteins, SHC and GRB2, have been found to bind to tyrosine-phosphorylated EGF/PDGF receptors via its SH2 domain (36, 37) . SHC protein was phosphorylated by activated EGF receptor or v-Src, whereas GRB2 was not phosphorylated but formed a specific complex with phosphorylated SHC (38) . These observations suggest that SHC and GRB2 couple growth factor receptors to a signaling pathway involved in cell proliferation. If the association of a phosphotyrosine-containing protein(s) with the exchange factor is required for its activation, a protein such as SHC or GRB2 might be a good candidate for regulator of the factor.
Which member of the exchange factor family catalyzes the exchange reaction of Ras in NIH 3T3 cells remains to be determined. In our data, the growth responsive exchange factor in NIH 3T3 cells specifically interacted with Ras but not RaplA and RablB. The exchange factor affinity-purified by anti-phosphotyrosine antibody-conjugated resins from total cell lysates did not crossreact with the anti-CDC25mm antibody, although Cen et al. (10) reported the crossreactivity of a 95-kDa protein in NIH 3T3 cells with the anti-CDC25mm antibody. Several investigators also found that neither the transcript nor the protein of the murine homologue of yeast S. cerevisiae CDC25 gene was detected in NIH 3T3 cells and that the gene was specifically expressed in brains (8, 11, 39) . Since mSOS is widely expressed in various types of cells including BALB/c 3T3 cells, mSOS may mediate the postulated regulatory roles of Ras in growth signaling.
Note. After the submission of our work, several investigators (40) (41) (42) (43) (44) (45) (46) published work describing the association of GRB2 with mSOS-1 and the complex formation of GRB2 with phosphorylated SHC in signal transmission from the EGF receptor or Src TPKs to Ras.
